Amfebutamone hydrochloride is a selective norepinephrine-dopamine reuptake inhibitor with IC50 of 6.5 and 3.4μM for the reuptake of dopamine and norepinephrine, respectively
Amfebutamone hydrochloride is a selective norepinephrine-dopamine reuptake inhibitor with IC50 of 6.5 and 3.4μM for the reuptake of dopamine and norepinephrine, respectively
Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory compound with acetic acid moiety.
Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory compound with acetic acid moiety.
Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory compound with acetic acid moiety.
AMG 232 is an extremely potent MDM2 inhibitor (SPR KD = 0.045 nM, SJSA-1 EdU IC50 = 9.1 nM), with remarkable pharmacokinetic properties and in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft model (ED50 = 9.1 mg/kg). *The compound is unstable in solutions, freshly prepared is recommended
AMG 232 is an extremely potent MDM2 inhibitor (SPR KD = 0.045 nM, SJSA-1 EdU IC50 = 9.1 nM), with remarkable pharmacokinetic properties and in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft model (ED50 = 9.1 mg/kg). *The compound is unstable in solutions, freshly prepared is recommended
AMG 232 is an extremely potent MDM2 inhibitor (SPR KD = 0.045 nM, SJSA-1 EdU IC50 = 9.1 nM), with remarkable pharmacokinetic properties and in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft model (ED50 = 9.1 mg/kg). *The compound is unstable in solutions, freshly prepared is recommended
AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the MET receptor.
AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the MET receptor.
AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the MET receptor.
AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the MET receptor.